^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    dronabinol oral

    i
    Other names: BX-1, ECP002A, delta9-THC, THC, PP-001
    Associations

    News

    Trials
    Company:
    Generic mfg.
    Drug class:
    Cannabinoid receptor agonist
    Related drugs:
    Associations

    News

    Trials
    28d
    Dronabinol As an Adjunct for Reducing Pain (DARP)-Texas Children's Hospital (clinicaltrials.gov)
    P2, N=0, Withdrawn, Baylor College of Medicine | N=75 --> 0 | Trial completion date: May 2028 --> Dec 2028 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2026 --> Mar 2028
    Enrollment change • Trial completion date • Trial withdrawal • Trial primary completion date
    |
    dronabinol oral
    2ms
    DEMURE: Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial (clinicaltrials.gov)
    P3, N=40, Not yet recruiting, Montefiore Medical Center | Trial completion date: Aug 2027 --> Dec 2027 | Initiation date: Jan 2026 --> May 2026 | Trial primary completion date: Aug 2027 --> Dec 2027
    Trial completion date • Trial initiation date • Trial primary completion date
    |
    Epidiolex (cannabidiol) • dronabinol oral
    2ms
    Tetrahydrocannabinol (THC) and Sleep (clinicaltrials.gov)
    P1, N=18, Completed, Oregon Health and Science University | Active, not recruiting --> Completed | Trial completion date: Apr 2025 --> Dec 2025
    Trial completion • Trial completion date
    |
    dronabinol oral
    3ms
    Clinical Study to Evaluate the Effects of Oral Delta-9-tetrahydrocannabinol (Δ9-THC) With and Without Alcohol on Perception and Driving Performance in Healthy Adults (clinicaltrials.gov)
    P1, N=48, Recruiting, Food and Drug Administration (FDA) | Not yet recruiting --> Recruiting | Initiation date: Sep 2025 --> Dec 2025
    Enrollment open • Trial initiation date
    |
    dronabinol oral
    5ms
    Synthetic THC And Blood Pressure (clinicaltrials.gov)
    P2/3, N=50, Not yet recruiting, Mayo Clinic
    New P2/3 trial
    |
    dronabinol oral
    5ms
    Sex Differences in Neurobehavioral Response to THC (clinicaltrials.gov)
    P2, N=40, Not yet recruiting, Medical University of South Carolina
    New P2 trial
    |
    dronabinol oral
    6ms
    PK/PD of Oral and Vaporized Delta-9-Tetrahydrocannabinol (THC) in Older Adults (clinicaltrials.gov)
    P1, N=20, Recruiting, Yale University | Trial primary completion date: Aug 2025 --> Jun 2026 | Trial completion date: Aug 2025 --> Aug 2026
    Trial completion date • Trial primary completion date
    |
    dronabinol oral
    6ms
    DEMURE: Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial (clinicaltrials.gov)
    P3, N=40, Not yet recruiting, Montefiore Medical Center | Trial completion date: Apr 2027 --> Aug 2027 | Initiation date: Sep 2025 --> Jan 2026 | Trial primary completion date: Apr 2027 --> Aug 2027
    Trial completion date • Trial initiation date • Trial primary completion date
    |
    Epidiolex (cannabidiol) • dronabinol oral
    6ms
    CRISP: Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain (clinicaltrials.gov)
    P2, N=60, Recruiting, Icahn School of Medicine at Mount Sinai | Trial completion date: Jun 2026 --> May 2027 | Trial primary completion date: Jun 2026 --> Apr 2027
    Trial completion date • Trial primary completion date
    |
    IL4 (Interleukin 4)
    |
    dronabinol oral
    7ms
    Dronabinol As an Adjunct for Reducing Pain (DARP)-Texas Children's Hospital (clinicaltrials.gov)
    P2, N=75, Not yet recruiting, Baylor College of Medicine | Initiation date: May 2025 --> Jan 2026 | Trial primary completion date: Dec 2027 --> Dec 2026
    Trial initiation date • Trial primary completion date
    |
    dronabinol oral
    7ms
    Clinical Study to Evaluate the Effects of Oral Delta-9-tetrahydrocannabinol (Δ9-THC) With and Without Alcohol on Perception and Driving Performance in Healthy Adults (clinicaltrials.gov)
    P1, N=48, Not yet recruiting, Food and Drug Administration (FDA)
    New P1 trial
    |
    dronabinol oral
    7ms
    DROSA: DRonabinol Treatment of OSA (clinicaltrials.gov)
    P1/2, N=120, Recruiting, VA Office of Research and Development | Not yet recruiting --> Recruiting
    Enrollment open
    |
    dronabinol oral